These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3962178)

  • 1. Optimum age for measles immunization in Romania.
    Biberi-Moroeanu S; Tiţeica-Boldeanu M; Munţiu A; Petrenco M; Suter C
    Virologie; 1986; 37(1):3-8. PubMed ID: 3962178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measles vaccine immunogenicity in 6- versus 15-month-old infants born to mothers in the measles vaccine era.
    Johnson CE; Nalin DR; Chui LW; Whitwell J; Marusyk RG; Kumar ML
    Pediatrics; 1994 Jun; 93(6 Pt 1):939-44. PubMed ID: 8190581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal age for vaccinating Nigerian children against measles. I. Neonatal antibody profile and subsequent susceptibility to measles.
    Harry TO; Ogunmekan DA
    Trop Geogr Med; 1981 Dec; 33(4):375-8. PubMed ID: 7342384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measles antibodies and response to vaccination in children aged less than 14 months: implications for age of vaccination.
    Borràs E; Urbiztondo L; Costa J; Batalla J; Torner N; Plasencia A; Salleras L; Domínguez À;
    Epidemiol Infect; 2012 Sep; 140(9):1599-606. PubMed ID: 22074684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of decline of maternal measles virus-neutralizing antibodies in sera of infants in France in 2006.
    Gagneur A; Pinquier D; Aubert M; Balu L; Brissaud O; De Pontual L; Gras Le Guen C; Hau-Rainsard I; Mory O; Picherot G; Stephan JL; Cohen B; Caulin E; Soubeyrand B; Reinert P
    Clin Vaccine Immunol; 2008 Dec; 15(12):1845-50. PubMed ID: 18815232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Age-related loss of maternal antibodies against measles in children in La Plata].
    del Buono MB; Vaschetti P; Iannicelli J; Silber R
    Rev Argent Microbiol; 2003; 35(2):102-5. PubMed ID: 12920993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evaluation of vaccination against measles at nine months of age (report of an epidemic).
    Ceyhan M; Kanra G; Vargel S; Işikçelik Y
    Turk J Pediatr; 1992; 34(3):127-33. PubMed ID: 1485379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Loss of maternal measles antibodies acquired by vaccination against measles].
    Strauss J; Mrázová M; Macátová I; Beranová I
    Cesk Epidemiol Mikrobiol Imunol; 1991 May; 40(3):137-43. PubMed ID: 1828716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal age for vaccinating Nigerian children against measles. II. Seroconversion to measles vaccine in different age groups.
    Ogunmekan DA; Harry TO
    Trop Geogr Med; 1981 Dec; 33(4):379-82. PubMed ID: 7342385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to measles vaccine in Haitian infants 6 to 12 months old. Influence of maternal antibodies, malnutrition, and concurrent illnesses.
    Halsey NA; Boulos R; Mode F; Andre J; Bowman L; Yaeger RG; Toureau S; Rohde J; Boulos C
    N Engl J Med; 1985 Aug; 313(9):544-9. PubMed ID: 4022091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The study of countermeasures on measles control in infants].
    Wang L; Sun L; Jiang Z; Kang S; Liu Y; Jiang X
    Zhonghua Liu Xing Bing Xue Za Zhi; 2001 Feb; 22(1):49-50. PubMed ID: 11860845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Passive transmission and persistence of naturally acquired or vaccine-induced maternal antibodies against measles in newborns.
    Leuridan E; Van Damme P
    Vaccine; 2007 Aug; 25(34):6296-304. PubMed ID: 17629601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune status following measles vaccination in infants and evaluation for the need of revaccination.
    Dutta AK; Singhal PK; Khare S; Kumari S; Mathur R; Mullick DN
    Indian Pediatr; 1989 Aug; 26(8):765-72. PubMed ID: 2620977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of vaccination with measles-mumps-rubella vaccine at 9, 12, and 15 months of age.
    Redd SC; King GE; Heath JL; Forghani B; Bellini WJ; Markowitz LE
    J Infect Dis; 2004 May; 189 Suppl 1():S116-22. PubMed ID: 15106100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroconversion after measles vaccination at nine and fifteen months of age.
    Işik N; Uzel N; Gökçay G; Kiliç A; Yilmaz G; Sadikoğlu B; Diri S
    Pediatr Infect Dis J; 2003 Aug; 22(8):691-5. PubMed ID: 12913768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of herd immunity in control of measles.
    Black FL
    Yale J Biol Med; 1982; 55(3-4):351-60. PubMed ID: 7180027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimum age for measles immunization in Malaysia.
    Chen ST; Lam SK
    Southeast Asian J Trop Med Public Health; 1985 Sep; 16(3):493-9. PubMed ID: 4095612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measles antibody levels in 3 to 9 months old infants.
    Dongre ST; Biranjan JR; Jalgaonkar SV; Polakhare JK
    Indian Pediatr; 1989 Aug; 26(8):775-9. PubMed ID: 2620978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vaccination against measles at 6 months of age].
    Kourouma K; Konde MK; Diallo MP; Conde M; Salomon H; Roussey M; Senecal J
    Ann Pediatr (Paris); 1992 Nov; 39(9):566-71. PubMed ID: 1334394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States.
    Gans HA; Yasukawa LL; Alderson A; Rinki M; DeHovitz R; Beeler J; Audet S; Maldonado Y; Arvin AM
    J Infect Dis; 2004 Jul; 190(1):83-90. PubMed ID: 15195246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.